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Abstract The aim of this study was to review current
evidence on interventional studies aimed at the prevention of
type 2 diabetes in Asian population with lifestyle interven-
tions. Prevalence of type 2 diabetes sharply increased inmost
Asian countries during the last decades. This issue has now
also relevant implication for Europe where different surveys
are also consistently revealing an higher prevalence of type 2
diabetes and other and major CVD risk factors among sub-
jects originating from Asian Countries than in the native
population. Nutrition and lifestyle transition seem to play a
role in disclosing the predisposition for the development of
type 2 diabetes and great interest is now shown toward the
possibility to intervene with lifestyle intervention on at risk
populations. A meta-analysis of Randomized Controlled
Trials showed that lifestyle interventions are highly effective
also in the Asian population. All studies were, however,
conducted with an individual approach based on the identi-
fication of high-risk individuals. When ethnic minority
groups have to be addressed, an approach directed to the
community rather than to the individual might, however, be
more effective. This review reinforces the importance for
policy-makers to consider the involvement of the whole
community of minority immigrant groups with lifestyle
intervention programs.
Keywords Type 2 diabetes prevention  Ethnicity 
Ethnic minority groups  IDF geographical regions  Meta-
analysis
Diabetes in Asia; which implications for Europe?
Asia is the epicentre of the global epidemic of type 2
diabetes mellitus (T2DM) [1]. Over 138 million people
with diabetes live in the Western Pacific area (98.4 million
in China) and 72 million in the South-East Asia area (65.1
million in India). Most Asian countries experienced a rel-
evant nutrition and lifestyle transition in the past few
decades that played a role in disclosing the predisposition
of Asian populations to the development of T2DM. China
presented an innovative approach showing the importance
of lifestyle intervention in the prevention of T2DM [2].
Other studies in the USA, Finland, Japan and India reached
similar rates of success [3–6]. In the same line, the
importance of physical exercise is now recognized in pre-
vention, and the discipline of sports medicine has begun to
widen its interests from athletes to cardiovascular and
metabolic diseases in populations [7–9]. The current
T2DM epidemic might thus be limited, and sustainable
programs have been launched at national levels [10–16].
Changes occurring in Asian countries have now impli-
cations also for Europe where a high prevalence of T2DM
is observed among Asian migrants originating from India,
Pakistan, Bangladesh, Sri Lanka, Nepal, Bhutan and the
Maldives [17–20]. For the majority of European countries,
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where immigration is a recent phenomenon, a common
assumption is that health promotion interventions effective
in the general population are also effective in ethnic
minorities. Therefore, only a few countries specifically
consider minority groups in their national health plans for
metabolic and cardiovascular prevention. Cultural factors
may, however, limit the ability of interventions addressed
at the native population to reach minority groups [21]. The
current relevant wave of immigration requires implemen-
tation of prevention strategies specifically addressed to
minority ethnic groups [22].
Ethnic origin and the risk of type 2 diabetes
Overweight and obesity are the main risk factors for the
development of new T2DM, and the importance of body
weight control is well recognized in prevention [21, 23].
Modest weight loss (5–10 % of body weight) and modest
physical activity (30 min daily) indeed offer a variety of
benefits in addition to the possibility of preventing or
delaying T2DM [21]. Rendering targeted advice to at-risk
individuals is thus especially imperative for physicians.
The main question is: Who is to be considered at high risk?
Subjects originating from South Asia, China, and Africa
develop T2DM at a higher rate, at an earlier age, and at
lower ranges of BMI than their European counterparts [24].
A clustering of different genetic defects or polymorphisms,
the ‘‘thrifty gene’’ hypothesis, a genetic susceptibility to
insulin resistance and higher central adiposity at similar
BMI levels, or epigenetic changes occurring during ges-
tation, might play a role in influencing metabolic pheno-
types of Asian populations [25–27]. For these reasons, the
WHO consultation group recommends a lower cutoff of
BMI for Asians with respect to native European popula-
tions [28]. The identified diagnostic cutoff for being
overweight is 23 kg/m2 in India, and 24 kg/m2 in China
[29, 30]. Proper consideration of this issue by European
physicians when facing these new patients in their offices
might increase opportunities for education, intervention,
and behaviour and lifestyle changes [31]. However, the
main scientific societies in Europe still give little attention
to the different cutoffs for overweight of ethnic minorities
[21].
Furthermore, although ethnic origin has a value ‘‘per se’’
in the estimation of the risk for T2DM, doctors often base
their prediction on blood glucose measured at opportunistic
screening [32–36]. The risk of developing T2DM is over 5
times higher in subjects with impaired glucose tolerance
(IGT) being 12 times higher in those with both IGT and
impaired fasting glucose (IFG) compared to normo-
glycemic individuals [37]. However, blood glucose has
limitations because (1) it is an invasive, costly, and time
consuming procedure; (2) it has a large random variation;
(3) when taken in the aggregate, age, family history of
T2DM, ethnicity, waist-to-hip ratio, BMI, blood pressure,
and lipid levels, combined with plasma glucose levels are
more predictive of future T2DM than glucose levels by
themselves; (4) most importantly, the opportunities for an
immigrant to have a blood test may be low, because of
cultural barriers (varying rates of literacy, limited motiva-
tion linked to the lack of education on healthy lifestyle) and
socioeconomic status [38–40]. Finally, primary prevention
should be addressed at high-risk subjects when they are
still in a normoglycemic state, and interventions should
prevent their transition from normoglycemia to IFG and
IGT. For these reasons, inexpensive, easily administered,
cost-effective, and validated non-invasive risk scores
(based on non-laboratory clinical variables) have been
made available [41, 42]. These non-invasive scores identify
a high risk of T2DM (C statistics C 0.8) with acceptable to
good discriminatory power across diverse settings in Eur-
ope [42–47]. Five non-invasive scores, the ARIC 2005,
ARIC 2009, AUSDRISK, DPoRT, and QD Score, include
the ethnic origin in the model [48–52]. To screen subjects
at risk for T2DM, the American Diabetes Association
(ADA) currently recommends a non-invasive tool that
includes ethnicity (available at the URL: http://www.ndep.
nih.gov/am-i-at-risk/diabetes-risk-test.aspx). A study per-
formed in the USA compared three risk scores in a multi-
ethnic population living in the same country [53]. In Eur-
ope, non-invasive tools were validated in different settings,
although none of the diverse setting included ethic minority
groups [42].
The possibility of preventing T2DM was demonstrated
in different studies, all including subjects on the basis of
blood glucose values [54]. Some randomized controlled
clinical trials were specifically conducted in Asian
populations.
Lifestyle interventions and prevention of type 2
diabetes in Asian populations
PUBMED and EMBASE were systematically searched for
randomized controlled clinical trials investigating the
effect of lifestyle interventions in preventing new T2DM in
Asian populations. Eligible studies were controlled ran-
domized clinical trials performed in Asian populations,
reporting incidence of new cases of T2DM, whatever the
duration of the study, published between 1994 and
December 2014. Randomized clinical trials including
patients with diabetes and duplicate publications or sub-
studies of included trials were excluded. Two investigators
independently abstracted the data from the eligible studies.
Disagreements were resolved via consensus. Search was
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conducted using terms, including type 2 diabetes mellitus,
non-insulin-dependent diabetes, prevention, pre-diabetes,
impaired fasting glucose (IFG), IGT, obesity, and lifestyle
modification, limiting search to randomized controlled
clinical trials and human studies. A manual search was also
performed on reference lists from articles, reviews, and
editorials. The measure of the effect of treatment was the
difference in the incidence of new cases of T2DM in the
intervention group and in the control group. For each study
included in the meta-analysis, the incidences of T2DM in
the control group and intervention group were used to
process the forest plot. Intervention effect (new cases of
T2DM) was expressed as odds ratio (OR), with 95 %
confidence intervals (CIs); meta-analysis was performed by
a random-effects model. Heterogeneity was examined with
the I2, where I2 values of 75 % or more indicated a high
level of heterogeneity. The meta-analysis followed the
PRISMA Checklist (Supplemental information) and was
conducted using Rev Man 5.0 software (Fig. 1).
Eight randomized controlled clinical trials studies
evaluated diet and physical activity interventions in Asian
adults [2, 5, 6, 55–59]. The main characteristics of the
included studies are reported in Table 1. The eight
prospective randomized clinical studies include a total
population of 2721 subjects at high risk for T2DM. All
T2DM prevention trials performed in Asian populations
have been based on a high-risk status defined by blood
tests. In all studies, the inclusion criteria indeed required
IGT, assessed with oral glucose tolerance test (OGTT), or
IFG [2, 5, 6, 55–59]. All eight RCTs were suitable for
inclusion in the meta-analysis showing a a 45 % reduction
in the incidence of new T2DM in Asian subjects assigned
to the intervention arm (OR 0.55; 95 % CI 0.44–0.70)
(Fig. 2). Most importantly, a low level of heterogeneity
was found among studies performed in different settings (I2
8 %).
The earliest Chinese study, published in 1997, started
activities in 1986 when the prevalence of T2DM in China
was still low (1–2 %) [2, 60, 61]. Pan et al. screened 577
men and women with IGT from a sample of 110,660
subjects. Subjects were then randomized to a programme of
diet, exercise, or both [2]. Dietary intervention was focused
on increased amounts of vegetables and reduced con-
sumption of alcohol and simple sugars; overweight indi-
viduals (those with a BMI[25 kg/m2) were encouraged to
lose weight. The exercise group was instructed to increase
their daily activity by an equivalent of 20 min of moderate
activity (brisk walking), and the diet-plus-exercise group
was asked to do both exercise and dietary modification.
After 6 years of follow-up, all three interventions were
similarly effective, with risk reductions of 31–46 % com-
pared to the control group. A recent long-term follow-up
shows that the reduction in the 20-year cumulative inci-
dence in the intervention groups (80 vs 93 % in the control
group) [62] is paralleled by a reduction in the long-term
cumulative incidence of CVD mortality (11.9 % in the
intervention group vs 19.6 % in the control group, HR
0.59; 95 % CI 0.36–0.96; p = 0.033) and all-cause mor-
tality (28.1 vs 38.4, HR 0.71; 95 % CI 0.51–0.99;
p = 0.049) [62]. These data are the first available showing
the impact on mortality of lifestyle intervention and are of
great value in a country where 40 % of subjects aged
19–29 years were recently found to have a blood glucose
level in the range of pre-diabetes [63].
In the study by Kosaka et al., 458 Japanese men with
IFG and IGT were assigned to lifestyle (n = 102) or
standard intervention (n = 356) [5]. OGTT was repeated
every 6 months, and at the 4-year follow-up the cumulative
incidence of T2DM was 9.3 and 3.0 % in the control and in
the intervention groups, respectively. The reduction in the
risk of T2DM is associated with larger body weight
reduction (0.39 and 2.18 kg, respectively).
In the Indian Diabetes Prevention Programme (IDPP-1),
10,839 native Asian Indians underwent the screening and
IGT was detected in 1027 subjects [6]. 1025 responded
when called for a confirmatory OGTT, and a total of 531
subjects diagnosed with IGT on both tests (persistent IGT)
were randomized into four groups (standard advice; life-
style intervention; metformin; lifestyle plus metformin).
Lifestyle intervention proved to be effective in this popu-
lation with a very high 3-year cumulative incidence ofFig. 1 Selection of studies for the meta-analysis
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Table 1 Randomized controlled clinical trials (RCT) performed in Asian populations
Author Year Inclusion criteria Ethnicity
(Country)
Duration
(months)
Arms Outcome
Pan et al. [2] 1997 IGT Chinese
(China)
72 Control: general written instructions on diet and
physical activity
Intervention: personalized instruction and
counselling for diet and physical exercise
New type 2
diabetes
Kosaka et al.
[5]
2005 Men; IFG and
IGT
Japanese
(Japan)
48 Control: for BMI 24 kg/m2, take 5–10 % smaller
meals than they had been taking and increase
physical activity (lose weight); for BMI\24 kg/
m2 avoid gaining weight by diet and exercise
Intervention: for BMI C22 kg/m2 subjects were
informed of their desirable body weight
individually (suggestion to reduce weight at a rate
of 0.5–1.0 kg/month); for BMI\22 kg/m2
maintain weight and not gain weight
New type 2
diabetes
Ramachandran
et al. [6]
2006 IGT on two
occasions
(persistent
IGT)
Indians
(India)
30 Control: subjects involved in physical labour, who
had to walk or cycle for[30 min/day, or
performing exercises regularly, were asked to
continue their routine activities. Sedentary subjects
were advised and regularly motivated to walk
briskly for at least 30 min each day
Intervention: subjects received advice on both
healthy diet and regular physical activity. Scores
were given based on the subjects’ adherence. Diet
modification including reduction in total calories,
refined carbohydrates and fats, avoidance of sugar,
and inclusion of fibre-rich foods
New type 2
diabetes
Sakane et al.
[56]
2011 IFG and IGT Japanese
(Japan)
36 Control: one group session on a healthy lifestyle and
prevention of diabetes. No individual guidance
was given during the study period
Intervention: specific advice on both healthy diet
and regular physical activity. Goals of
intervention: reduce body weight by 5 % in
overweight and obese subjects, and to increase
energy expenditure due to leisure time physical
activity by 700 kcal per week. Advise: take the
proper amount of calories; decrease the mean
percent of energy derived from dietary fat
(\25 %); restrict daily alcohol consumption
(\160 kcal); eat three meals a day and avoid
eating late at night; achieve the exercise goal,
aerobic exercise such as walking is recommended
New type 2
diabetes
Saito et al. [55] 2011 Overweight with
IFG and IGT
Japanese
(Japan)
36 Control: reduce total energy intake and increase
physical activity (5 % reduction in body weight),
through the help of nurses, dieticians, physical
therapists, and physicians. Instructions: four times
at 12-month intervals
Intervention: reduce total energy intake and increase
physical activity (5 % reduction in body weight),
through the help of nurses, dieticians, physical
therapists, and physicians. Individual instructions
and follow-up support from the medical staff at
least nine times. Follow-up visits and use of self-
monitoring sheets for recording body weight,
pedometer counts, and how close they came to
attaining their goals. Dietary intervention: reduce
total energy intake mainly by restricting excess
intake of fat or carbohydrates (fat intake at
20–25 % of total energy intake; carbohydrate
intake at 55–60 % of total energy intake)
New type 2
diabetes
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Table 1 continued
Author Year Inclusion criteria Ethnicity
(Country)
Duration
(months)
Arms Outcome
Iqbal Hydrie
et al. [57]
2012 Age[30 years;
IGT
Pakistani
(Pakistan)
18 Control: subjects received general diet and exercise
information at baseline and at subsequent visits; no
intensive individual specific counselling was given
Intervention: training sessions and counselling were
given to subjects in the intervention group about
intervention goals (body weight loss C5 % via diet
control and physical exercise, total fat intake
\30 % of energy consumed, fibre intake of 15 g/
1000 kcal, and moderate exercise[30 min/day).
Sessions with dieticians and physical trainers at
each visit and individual counselling to increase
physical activity (endurance exercises such as
walking, jogging, and cycling)
New type 2
diabetes
Ramachandran
et al. [58]
2013 Men; owning a
mobile phone;
familial history
of type 2
diabetes; BMI
[23 kg/m2;
IGT
Indians
(India)
20 Control: personalized education and motivation
about health lifestyle principles, and written
information about diet and physical activity
Intervention: in addition, a manager website
delivered cyclically phone message reminders
(2–4 message per week, not the same message in a
6-month period)
New type 2
diabetes
Bhopal et al.
[59]
2014 IFG; IGT; waist:
[90 cm M or
[80 cm in W
South
Asians
(UK)
36 Control: standardized written and verbal advice
Intervention: consultation with a dietitian (both
participants and family volunteers were part of this
intervention) with 15 visits over 3 years (baseline,
monthly for the first 3 months, then every
3 months) on achieving weight loss through a
calorie-deficit diet and physical activity ([30 min
daily brisk walking), using culturally adapted and
translated resources (information on shopping and
cooking; 3-day food diaries; dietary patterns
questionnaire). Annual group sessions, including a
food shopping tour and brisk walking. Pedometers
were given to provide step counts for motivation
through self-monitoring and for the dietitians to
assess progress. Bodyweight and waist
circumference data were used as motivational
devices by dietitians
Weight change at
3 years
Fig. 2 Odds ratio for the reduction of type 2 diabetes in randomized clinical trials which evaluated the effects of non-pharmacologic lifestyle
interventions (physical exercise and diet) in Asian adults
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T2DM (55, 39, 40 and 39 % in groups 1–4, respectively)
[6].
Sakane et al. performed a lifestyle intervention program
in a primary health-care setting on 304 middle-aged Japa-
nese subjects with IGT [56]. The 3-year cumulative inci-
dence tended to be lower in the intervention group (14.8 vs
8.2 %).
The incidence of T2DM was high in the 641 Japanese
overweight subjects (aged 30–60 years) with IFG and IGT
enrolled by Saito et al. [55]. At 36 months follow-up, the
estimated cumulative incidences of T2DM were 12.2 % in
the frequent intervention group (n = 311) and 16.6 % in
the control group (n = 330).
In the study performed in Pakistan by Iqbal Hydrie et al.,
5000 people attended screening camps where 2300 persons
filled the questionnaire and 1825 subjects were identified to
be at high risk [57]. Of the 1739 subjects who took the oral
glucose tolerance test, 317 were identified as IGT and
randomized into three groups (control; intense lifestyle
modification advice; intense lifestyle modification advice
and metformin 500 mg twice daily). The overall incidence
was 4 cases per 1000 person-months, with an incidence of
8.6 cases in the control group, 2.5 cases in the lifestyle
modification advice group, and 2.3 cases in the lifestyle
modification advice ? drug group. The overall compliance
rate was 86 %.
An innovative technological approach based on mobile
phone messaging in the prevention of T2DM was explored
by Ramachandran et al. who screened male Indian subjects
with positive familial history of T2DM or BMI[23 kg/m2
before performing the IGT test [45, 58]. In this Indian
study, the 537 working Indian men with IGT were ran-
domly allocated to receive mobile phone messages
(n = 271) or standard care (n = 266). All participants
received diet and exercise advice at baseline. The cumu-
lative incidence of T2DM was significantly reduced in the
intervention group compared with the standard-care group
[50 (18 %) of 271 participants vs 73 (27 %) of 266; hazard
ratio 0.64, 95 % CI 0.45–0.92; p = 0.015]. The trial is the
first to report a reduction in the onset of T2DM with a
mobile messaging intervention. The investigators recorded
a high response rate of 96 % (n = 517) with a duration of
follow-up of 2 years. The nature of the intervention pre-
vented masking of the participants and field staff; however,
the laboratory staff and the principal and co-investigators
were masked [58]. If the results of this trial are replicated
in other settings, mobile phone messaging might be a
practical and affordable way to deliver lifestyle advice to
delay or prevent the onset of T2DM.
The first study investigating the effects of lifestyle
modifications on progression to T2DM in South Asians
(Indian or Pakistani) living in the UK was recently per-
formed by Bhopal et al. [59]. Subjects aged 35 years or
older, with waist circumference 90 cm or greater in men or
80 cm or greater in women (n = 1319), were screened by
oral glucose tolerance test; 196 (15 %) had IGT or IFG and
171 entered the trial and were randomized to intervention
(78 families with 85 participants) or control (78 families
with 86 participants). Interestingly, the protocol considered
the supporting role of the family as important, because
participants in the same family were not randomized sep-
arately. At 3 years, progression to T2DM (either doctor
diagnosed or by oral glucose tolerance test at 3 years) was
observed less frequently in the intervention group (15 %)
than the control group (21 %), although the difference was
not statistically significant (95 % CI 0.27–1.67;
p = 0.3705).
This meta-analysis is associated with several important
limitations. First, this review is limited to published ran-
domized controlled trials, while observational studies and
additional unpublished literature are excluded. Although
randomized controlled trials generally provide maximum
validity and causal inference, non-randomized studies
performed at the community level may have been lost.
Second, only one study included in the meta-analysis
enrolled Asian subjects living in Europe. Further research
is therefore needed to better identify effective interventions
for the prevention of T2DM in Asian minority groups
living in Europe, an issue now crucial for Europe [64].
Third, we did not include subjects from America or Africa,
which may limit the generalizability of our results to
African or other populations.
Notwithstanding these limitations, current randomized
clinical trials seem to indicate that T2DM can be prevented
in Asian individuals who are at high risk. However, when
the intervention is targeted at Asian communities living in
Europe, some aspects have to be considered.
A new perspective for lifestyle interventions
in minority groups: from individual to collectivist
goals
The main limitations in the high-risk approach to minority
groups are represented by costs of the screening procedure,
low compliance at follow-up, and the problematic contact
with undocumented migrants.
A comparison of potential screening strategies and
subsequent interventions for the prevention and treatment
of T2DM was performed by Gillies et al., who considered a
hypothetical population of the UK, aged 45 years, at the
time of screening [65]. In their estimation, lifestyle inter-
vention strategy shows a small clinical potential benefit in
terms of average years spent without T2DM and cases of
T2DM prevented, because discounted QALYs gained
compared with no screening were 0.09 (0.03–0.17) for
Intern Emerg Med
123
screening and lifestyle interventions. The hypothetical
population had 17 % of either IGT or undiagnosed T2DM
at the time of screening. However, as noted by Gillies et al.,
when an increased prevalence of IGT and T2DM are
considered, the QALYs decrease, and most importantly the
total costs of the screening strategy increase [65]. When the
model was run for a South Asian cohort, with high
prevalence of T2DM, the results for QALYs were reduced
and costs of screening increased. Notwithstanding these
limitations, Gillies et al. consider lifestyle interventions to
be cost-effective compared with no screening in an ‘‘at-
risk’’ population [65].
A recent trial performed in the Netherlands studied the
effectiveness of an intensive, culturally targeted lifestyle
intervention in general practice for weight status and
metabolic profile of South Asians at risk of T2DM [66].
Although T2DM incidence is not included among out-
comes, the trial is of great interest because limitations
connected with the high-risk approach in minority groups
are clearly shown. Low initial response rate and laborious
recruitment, high dropout rate, and the lack of effect of the
lifestyle intervention on weight change and other metabolic
parameters indeed led the authors to raise the question
whether the high-risk strategy is the optimal approach to
prevent T2DM in minority groups [66]. Admiraal et al.
conclude that health gain might be better achieved by
focusing on prevention strategies that tackle the high risk
of T2DM among South Asians at an earlier stage [67].
The large number of subjects not included in population
statistics (hidden population of undocumented migrants) is
also often not considered in trials and cost-effectiveness
analysis. Approximately, 1.7 million Chinese people are
now estimated to live in Europe, mostly in the UK, France,
Italy, Germany, and Spain, and migration from China to
Europe has now been mainly concentrated in countries of
Southern Europe, e.g. Italy and Spain [68]. In China, a
prevalence of T2DM of 11.6 %, with over 40 % of young
adults (aged 18-to-29 years) at risk was found in 2010 [63,
69]. Should the prevalence of prediabetes and T2DM in the
Chinese living in Europe be as high as in China, the pre-
vention of T2DM could be a need for our health system
[63, 70]. Many minority patients have difficulty commu-
nicating with their health-care providers and other cultural
barriers may exist [71]. A qualitative study performed in
the UK identifies a main barrier for the Bangladeshi
community in the complex value hierarchy of what is
accepted to be healthy (small portion size, limited rich and
fatty food, regular activity) and what is important for the
social norms of hospitality, the religious requirement for
modesty, and the cultural rejection of a ‘‘sporting’’ identity
or dress (especially for women, older people, and senior
members of the society) [72]. Contemporary health
promotion, usually based on assumptions of a self-invest-
ment, should thus leave the approach to individuals when
the aim is to involve societies with a collectivist history
[73]. This paradigm change is now required by an ever-
changing society.
On this basis, a new strategic plan aimed at the pre-
vention of new T2DM in the Chinese community settled in
Prato has been approved recently in Italy by the Regione
Toscana. The project aim is to encourage weight control
and physical activity with interventions on the Chinese
community. The local Chinese school will be the setting to
contact families. The project will include: distribution of
the population of Chinese training materials on T2DM and
the correct rules on nutrition and lifestyles; training courses
on the importance of nutrition in the prevention of T2DM
directed at teachers of the Chinese School and to canteen
managers of Chinese factories; promotion of physical
activity through the creation of sports groups aggregation
of Chinese entities for the realization of projects of sport
activity (formation of teams with structured training cour-
ses, realization of tournaments and amateur competitions).
Objectives for action include the reduction of 5 % loss of
body weight through the control diet (total intake of fat less
than 30 % of energy consumed, fibre intake per day of
15 g/1000 kcal) and the promotion of moderate exercise
(30 min/day with resistance exercises such as walking,
jogging, and cycling).
Conclusion
The review identifies three issues to be considered in pri-
mary care: (1) ethnic origin is an important element for risk
assessment of future T2DM, and specific diagnostic cutoffs
for overweight have to be considered in general practice;
(2) lifestyle interventions are particularly important to
reduce the future incidence of T2DM in the Asian popu-
lation living in Europe; (3) the approach to individual high-
risk subjects followed in randomized controlled trials is
effective, although limitations exist when pursued in
minority groups and a new perspective for an approach
specifically involving the whole communities is now nee-
ded for Europe.
It is now important to launch public health promotion
programs of primary prevention, specifically addressed to
minority groups, and the cooperation of ethnic communi-
ties is essential. Educational prevention programs are
important to limit the development of new T2DM in
Europe.
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